As Part of the Remote Patient Monitoring Plan, two tracks were being produced for patients with COVID-19: one for patients with comorbidities at moderate to higher hazard for problems and one for reduce-chance patients. FDA approvals are crucial to ensure that remote patient monitoring systems and gadgets fulfill regulatory specifications. https://cmsgp.health/ccm.php